APL-FINASTERIDE finasteride 5 mg tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

finasteride, Quantity: 5 mg

MAH:

Strides Pharma Science Pty Ltd

INN:

Finasteride

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: pregelatinised maize starch; lactose monohydrate; sodium starch glycollate type A; microcrystalline cellulose; magnesium stearate; docusate sodium; titanium dioxide; hypromellose; hyprolose; purified talc; iron oxide yellow; indigo carmine aluminium lake

administration_route:

Oral

units_in_package:

28, 30

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

APL-FINASTERIDE is indicated for the treatment of patients with symptomatic benign prostatic hyperplasia (BPH) with an enlarged prostate.

leaflet_short:

Visual Identification: Blue coloured, circular, biconvex, bevel edged film-coated tablets debossed with 'E' on side and '61' on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2014-04-30